跳转至内容
Merck
CN

Negative feedback loop between ZBTB7A and TGF-β in breast cancer.

Oncology letters (2017-08-10)
Yingying Shen, Renxian Cao, Wen Liu, Yuqing Zhou, Ying Wu, Jingjing Tan, Min Jin, Jing Zhong, Qinghai Zhang, Jianghua Liu, Xuyu Zu
摘要

Zinc finger and BTB domain containing 7A (ZBTB7A) is aberrantly expressed in breast cancer, but the involvement of ZBTB7A in breast cancer remains controversial. Transforming growth factor-β (TGF-β) is a pleiotropic cytokine which promotes breast cancer metastasis. ZBTB7A and TGF-β are important factors in tumor development. However, the association between ZBTB7A and TGF-β in breast cancer remains unknown. The results of the present study revealed that TGF-β1 induced the expression of ZBTB7A via the phosphoinositide 3-kinase-protein kinase B signaling pathway in human breast cancer cells, and ZBTB7A inhibited the expression of TGF-β1 through indirectly suppressing the promoter activity of TGF-β1. Furthermore, no significant correlation between the expression of ZBTB7A and TGF-β1 were identified in breast cancer tissues using tissue microarray assay and human cancer genomics analysis. These results have identified a negative feedback loop between ZBTB7A and TGF-β signaling, suggesting ZBTB7A as a potential modulator of breast cancer metastasis. Thus, the results of the present study suggested that ZBTB7A is a potential prognostic biomarker for breast cancer.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
山羊抗兔IgG抗体,过氧化物酶偶联, 1 mg/mL (after reconstitution), Chemicon®